CBIO

Crescent Biopharma, Inc. $13.54 as of 2026-11-06
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.5%
Next 1 week
+0.5%
Next 1 month
+1.4%
Seasonality
Bullish window historically
Next 30 days (to Dec 8): +1.5% median, 64% of the last 11 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 62
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.51%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.07 +1.4% · Seasonal tilt (11y) +0.0%
$3M/day volume 81% volatility +9% 1-year
52-week range · 26% of the way up · -51% from the high
$8.72$27.41

Earnings Full history →

No scheduled report date yet.

Biggest pop
+6.8%
Biggest drop
-1.4%

Standard deviation of the close-to-close move over the last 6 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-07-30 beat -0.64 -0.62 +2.8% -0.7% +1.7% +11.2%
2026-04-29 beat -0.95 -0.70 +26.0% -0.2% +6.8% -14.0%
2026-02-26 miss -2.82 -4.92 -74.5% -1.6% -1.1% -9.3%
2025-11-06 beat -1.38 -1.37 +1.3% +0.1% +5.4% +4.4%
2025-07-31 miss -3.68 -3.72 -1.1% -2.2% -1.4% -12.7%
2025-06-18 miss -3.64 -18.39 -405.2% +8.5% +2.6% +8.8%

Not investment advice.